MDT

96.54

1.00% 0.96

Handel nachbörslich: 96.81 0.27 +0.28%

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$95.58

Offen:

$95.26

24-Stunden-Volumen:

4.86M

Relative Volume:

0.71

Marktkapitalisierung:

$123.83B

Einnahmen:

$34.20B

Nettoeinkommen (Verlust:

$4.69B

KGV:

26.66

EPS:

3.6218

Netto-Cashflow:

$5.30B

1W Leistung:

-1.82%

1M Leistung:

+2.67%

6M Leistung:

+14.63%

1J Leistung:

+7.25%

1-Tages-Spanne:

$95.26

$96.60

1-Wochen-Bereich:

$95.06

$98.68

52-Wochen-Spanne:

$79.29

$99.37

Medtronic Plc Stock (MDT) Company Profile

Firmenname

Medtronic Plc

Sektor

Healthcare (1140)

Branche

Medical Devices (147)

Telefon

01135314381700

Adresse

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Mitarbeiter

95,000

Twitter

@Medtronic

Nächster Verdiensttermin

2025-08-19

Neueste SEC-Einreichungen

MDT's Discussions on Twitter

Vergleichen Sie MDT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDT Medtronic Plc	96.54	122.60B	34.20B	4.69B	5.30B	3.6218
ABT Abbott Laboratories	133.27	228.66B	43.11B	13.94B	6.78B	7.9963
BSX Boston Scientific Corp	96.24	140.69B	18.49B	2.50B	3.49B	1.6801
SYK Stryker Corp	370.00	139.51B	23.82B	2.92B	4.02B	7.5574
EW Edwards Lifesciences Corp	73.36	42.83B	5.69B	1.41B	577.90M	6.9828

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-30	Hochstufung	Wolfe Research	Underperform → Peer Perform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-03-04	Hochstufung	Citigroup	Neutral → Buy
2024-10-10	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Bestätigt	Oppenheimer	Perform
2024-08-15	Hochstufung	UBS	Sell → Neutral
2024-08-14	Herabstufung	Stifel	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Sell
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-29	Herabstufung	UBS	Buy → Sell
2023-01-09	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Herabstufung	Citigroup	Buy → Neutral
2022-11-23	Herabstufung	Oppenheimer	Outperform → Perform
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-13	Eingeleitet	Mizuho	Buy
2022-10-12	Eingeleitet	Jefferies	Hold
2022-08-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-06-01	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-10	Herabstufung	BTIG Research	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-16	Herabstufung	Wells Fargo	Overweight → Equal Weight
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-06-10	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-12-15	Hochstufung	Goldman	Sell → Neutral
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-10-08	Hochstufung	Stifel	Hold → Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-05-14	Herabstufung	DZ Bank	Buy → Hold
2020-03-30	Herabstufung	Needham	Strong Buy → Buy
2020-03-25	Hochstufung	DZ Bank	Hold → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Sell
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-02	Hochstufung	Guggenheim	Neutral → Buy
2019-06-05	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-02-04	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2019-01-02	Herabstufung	Citigroup	Buy → Neutral
2018-12-19	Hochstufung	JP Morgan	Neutral → Overweight
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-08-27	Bestätigt	Argus	Buy

Alle ansehen

Medtronic Plc Aktie (MDT) Neueste Nachrichten

12:52 PM

Medtronic launches Avalus Ultra™ surgical valves in India - BioSpectrum India

12:52 PM

08:14 AM

Leerink Partners Adjusts Price Target on Medtronic to $114 From $111, Maintains Outperform Rating - MarketScreener

08:14 AM

07:43 AM

Mizuho Adjusts Price Target on Medtronic to $115 From $100, Maintains Outperform Rating - MarketScreener

07:43 AM

04:52 AM

Tools to monitor Medtronic plc recovery probability2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com

04:52 AM

03:03 AM

Is Medtronic plc stock ready for a breakout2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com

03:03 AM

Oct 13, 2025

How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Oct 13, 2025

Medtronic Stent Graft System Receives FDA Labeling Approval to Remove rAAA Treatment Warning - Diagnostic and Interventional Cardiology

Oct 13, 2025

Medtronic earns first-of-its-kind FDA labeling for Endurant stent graft - MassDevice

Oct 13, 2025

Medtronic Hugo robotic IDE trial targets gynaecology surgery precision and outcomes - Medical Device Network

Oct 13, 2025

Verdence Capital Advisors LLC Has $2.56 Million Stock Position in Medtronic PLC $MDT - MarketBeat

Oct 13, 2025